Heyman Richard A.

Enliven Therapeutics, Inc. · Director

Heyman Richard A. is listed in public filings as director. This Heyman Richard A. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN), ORIC Pharmaceuticals, Inc. (ORIC), and PMV Pharmaceuticals, Inc. (PMVP). Investors use Heyman Richard A.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Enliven Therapeutics, Inc.ELVN	$593k22.6k shares	SellFeb 17, 2026	$32.2K1.2k shares	$26.18	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Enliven Therapeutics, Inc.ELVN	$522k19.2k shares	Grant / ExerciseFeb 12, 2026	$522.4K19.2k shares	$27.16	--
Enliven Therapeutics, Inc.ELVN	$644k23.9k shares	SellJan 20, 2026	$19.4K718 shares	$26.96	--
Enliven Therapeutics, Inc.ELVN	$651k24.6k shares	SellJan 20, 2026	$13.5K512 shares	$26.46	--
ORIC Pharmaceuticals, Inc.ORIC	$502k41.8k shares	SellJan 16, 2026	$42.0K3.5k shares	$12.00	--
ORIC Pharmaceuticals, Inc.ORIC	$2.6M213.1k shares	SellJan 16, 2026	$38.4K3.2k shares	$12.00	--
Enliven Therapeutics, Inc.ELVN	$628k25.1k shares	SellJan 9, 2026	$107.1K4.3k shares	$25.00	--
Enliven Therapeutics, Inc.ELVN	$736k29.4k shares	SellJan 8, 2026	$200.7K8k shares	$25.04	--
Enliven Therapeutics, Inc.ELVN	$639k25.5k shares	SellJan 8, 2026	$40.5K1.6k shares	$25.00	--
ORIC Pharmaceuticals, Inc.ORIC	$327k40k shares	Grant / ExerciseJan 2, 2026	$326.8K40k shares	$8.17	--
ORIC Pharmaceuticals, Inc.ORIC	$70k43.9k shares	Grant / ExerciseOct 3, 2025	$50.2K31.4k shares	$1.60	--
ORIC Pharmaceuticals, Inc.ORIC	$018.1k shares	Grant / ExerciseOct 3, 2025	$29.0K18.1k shares	$1.60	--
ORIC Pharmaceuticals, Inc.ORIC	$54k33.7k shares	Grant / ExerciseOct 3, 2025	$21.2K13.2k shares	$1.60	--
ORIC Pharmaceuticals, Inc.ORIC	$170k45.3k shares	Grant / ExerciseOct 3, 2025	$5.4K1.4k shares	$3.75	--
PMV Pharmaceuticals, Inc.PMVP	$32k33.5k shares	Grant / ExerciseJun 5, 2025	$31.8K33.5k shares	$0.95	--
Enliven Therapeutics, Inc.ELVN	$517k23k shares	Grant / ExerciseFeb 6, 2025	$517.1K23k shares	$22.47	--
ORIC Pharmaceuticals, Inc.ORIC	$289k35k shares	Grant / ExerciseJan 2, 2025	$289.1K35k shares	$8.26	--
Enliven Therapeutics, Inc.ELVN	$3.7M123.7k shares	SellOct 18, 2024	$24.5K817 shares	$30.00	--
Enliven Therapeutics, Inc.ELVN	$815k27.2k shares	SellOct 18, 2024	$22.6K753 shares	$30.00	--
Enliven Therapeutics, Inc.ELVN	$3.4M124.5k shares	SellOct 15, 2024	$35.1K1.3k shares	$27.67	--
Enliven Therapeutics, Inc.ELVN	$3.5M125.8k shares	SellOct 4, 2024	$77.7K2.8k shares	$27.51	--
Enliven Therapeutics, Inc.ELVN	$3.5M128.6k shares	SellOct 1, 2024	$14.3K518 shares	$27.54	--
Enliven Therapeutics, Inc.ELVN	$2.9M129.1k shares	SellSep 16, 2024	$28.5K1.3k shares	$22.41	--
Enliven Therapeutics, Inc.ELVN	$3.0M131k shares	SellAug 15, 2024	$14.8K650 shares	$22.82	--
Enliven Therapeutics, Inc.ELVN	$3.1M130.4k shares	SellAug 15, 2024	$14.7K620 shares	$23.70	--
Enliven Therapeutics, Inc.ELVN	$3.6M131.6k shares	SellJul 31, 2024	$46.8K1.7k shares	$27.51	--
Enliven Therapeutics, Inc.ELVN	$768k27.9k shares	SellJul 31, 2024	$17.8K649 shares	$27.50	--
Enliven Therapeutics, Inc.ELVN	$3.3M133.3k shares	SellJul 15, 2024	$31.5K1.3k shares	$24.80	--
Enliven Therapeutics, Inc.ELVN	$2.9M134.6k shares	SellJun 17, 2024	$27.3K1.3k shares	$21.48	--
ORIC Pharmaceuticals, Inc.ORIC	$202k25.6k shares	Grant / ExerciseJun 12, 2024	$202.2K25.6k shares	$7.90	--